Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
University Hospital Carl Gustav Carus · Vienna General Hospital · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
960
total citations
- FWCI
- 35.02
- Percentile
- 100%
- References
- 38
Citations per year
Authors
18Topics & keywords
Topics
Keywords
- Medicine
- Folinic acid
- Clinical endpoint
- FOLFIRI
- Oxaliplatin
- Cetuximab
- Irinotecan
- Response Evaluation Criteria in Solid Tumors
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.